I agree that this site is using cookies. You can find further informations here.
X
Carlo Gambacorti-Passerini
385  results:
Search for persons X
?
1

Whole Exome Sequencing reveals NOTCH1 mutations in anaplast..:

Hugo Larose ; Nina Prokoph ; Jamie D. Matthews...
Haematologica.  106 (2020)  6 - p. 1693-1704 , 2020
Link: https://doi.org/10.3324/..
 
?
2

miR-15a targets the HSP90 co-chaperone Morgana in chronic m..:

Poggio, Pietro ; Rocca, Stefania ; Fusella, Federica...
Scientific Reports.  14 (2024)  1 - p. , 2024
Link: https://doi.org/10.1038/..
 
?
3

Efficacy and safety of bosutinib in patients treated with p..:

Smith, B. Douglas ; Brümmendorf, Tim H. ; Roboz, Gail J....
Leukemia Research.  139 (2024)  - p. 107481 , 2024
Link: https://doi.org/10.1016/..
 
?
4

Repurposing pexmetinib as an inhibitor of TKI-resistant BCR..:

Fontana, Diletta ; Malighetti, Federica ; Villa, Matteo...
Leukemia.  , 2024
Link: https://doi.org/10.1038/..
 
?
5

Late relapse of chronic myeloid leukemia after allogeneic b..:

Fontana, Diletta ; Zambrotta, Giovanni Paolo Maria ; Scannella, Antonio..
Annals of Hematology.  103 (2024)  5 - p. 1561-1568 , 2024
Link: https://doi.org/10.1007/..
 
?
6

PB1966: THE EFFECT OF BODY MASS INDEX ON THE SAFETY OF BOSU..:

Isfort, Susanne ; Gambacorti-Passerini, Carlo ; Brümmendorf, Tim H...
HemaSphere.  7 (2023)  S3 - p. e07598aa , 2023
Link: https://doi.org/10.1097/..
 
?
7

Analogies between COVID-19 and Preeclampsia: Focus on Thera..:

Giardini, Valentina ; Gambacorti-Passerini, Carlo ; Casati, Marco..
International Journal of Translational Medicine.  3 (2023)  2 - p. 203-216 , 2023
Link: https://doi.org/10.3390/..
 
?
8

P667: RISK OF PROGRESSION IN CHRONIC PHASE-CHRONIC MYELOID ..:

Paolo Maria Zambrotta, Giovanni ; Assouline, Sarit ; Nicolini, Franck E....
HemaSphere.  7 (2023)  S3 - p. e68411a2 , 2023
Link: https://doi.org/10.1097/..
 
?
9

DNA Damage Response (DDR) Is Associated With Treatment-free..:

Malighetti, Federica ; Arosio, Giulia ; Manfroni, Chiara...
HemaSphere.  7 (2023)  3 - p. e852 , 2023
Link: https://doi.org/10.1097/..
 
?
10

POSTER: ALL-300 First Report of PhALLCON: A Phase 3 Study C..:

Jabbour, Elias ; Kantarjian, Hagop ; Aldoss, Ibrahim...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S154 , 2023
Link: https://doi.org/10.1016/..
 
?
11

P1175: THROMBOTIC RISK IN DLBCL: A REAL-LIFE COMPARISON OF ..:

Civettini, Ivan ; Cavalca, Fabrizio ; Zappaterra, Arianna...
HemaSphere.  7 (2023)  S3 - p. e27260d1 , 2023
Link: https://doi.org/10.1097/..
 
?
12

A monocentric analysis of the long-term safety and efficacy..:

Rindone, Giovanni ; Aroldi, Andrea ; Bossi, Elisa...
Blood Advances.  7 (2023)  3 - p. 314-316 , 2023
Link: https://doi.org/10.1182/..
 
?
13

ALL-300 First Report of PhALLCON: A Phase 3 Study Comparing..:

Jabbour, Elias ; Kantarjian, Hagop ; Aldoss, Ibrahim...
Clinical Lymphoma Myeloma and Leukemia.  23 (2023)  - p. S245 , 2023
Link: https://doi.org/10.1016/..
 
?
14

PB2182: NEUTROPHIL TO LYMPHOCYTE RATIO (NLR) AT DIAGNOSIS I..:

Ripamonti, Alessia ; Cavalca, Fabrizio ; Agostani, Elena..
HemaSphere.  7 (2023)  S3 - p. e0805349 , 2023
Link: https://doi.org/10.1097/..
 
?
15

S110: PHALLCON: A PHASE 3 STUDY COMPARING PONATINIB VERSUS ..:

Jabbour, Elias ; Kantarjian, Hagop ; Aldoss, Ibrahim...
HemaSphere.  7 (2023)  S3 - p. e68516d0 , 2023
Link: https://doi.org/10.1097/..
 
1-15